25 May 2013
Keywords: headlines, years, ago, week, fda, approves, squibb
Article | 10 April 2006
US FDA approves Squibb's antihypertensive Capoten (captopril), leading analysts to forecast sales of the drug at $250.0 million a year by 1985
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com